Jean-Paul Renaud is a co-founder, President, and CSO at Urania Therapeutics, where he applies his Ph. D. in developing drugs for genetic diseases. A respected scientist and entrepreneur, he also co-founded NovAliX and chairs its "Biophysics in Drug Discovery" conference. Colleagues describe him as a brilliant, honest, and clever business partner.
Beyond his extensive scientific work, Jean-Paul demonstrates an appreciation for fine art. He has shared paintings from the Impressionist era, such as works by John Singer Sargent, indicating a potential personal interest in late 19th-century European and American art.
Unique fact: He successfully transitioned from a career in French public research labs to co-founding two separate biopharmaceutical companies.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.